| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/30/1999 | WO1999042465A3 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 09/30/1999 | WO1999038499A3 Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion |
| 09/30/1999 | WO1999035266A3 Human urotensin ii |
| 09/30/1999 | WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 09/30/1999 | CA2325943A1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 09/30/1999 | CA2325634A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 09/30/1999 | CA2324999A1 Methods for decreasing .beta.-amyloid protein |
| 09/30/1999 | CA2324612A1 Paroxetine compositions |
| 09/30/1999 | CA2324566A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 09/30/1999 | CA2324266A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors |
| 09/30/1999 | CA2323782A1 Methods for prevention and treatment of cancer |
| 09/30/1999 | CA2323640A1 Human calcium-binding proteins |
| 09/30/1999 | CA2320204A1 Use of cabergoline in the treatment of restless legs syndrome |
| 09/29/1999 | EP0945512A2 Novel serine proteases |
| 09/29/1999 | EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 09/29/1999 | EP0945135A2 Treatment of alzheimer's disease and modulation of immune system with Delta5-Androstenes |
| 09/29/1999 | EP0945134A1 New galenic formulations of meloxicam for oral administration |
| 09/29/1999 | EP0945133A1 Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator |
| 09/29/1999 | EP0945132A2 Ibuprofen composition |
| 09/29/1999 | EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 09/29/1999 | EP0944630A1 Xanthines and their therapeutic use |
| 09/29/1999 | EP0944626A1 Tropane derivatives and method for their synthesis |
| 09/29/1999 | EP0944622A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944621A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944620A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944618A1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
| 09/29/1999 | EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use |
| 09/29/1999 | EP0944612A1 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 09/29/1999 | EP0944611A1 Dimesylate salts of neuropeptide y ligands |
| 09/29/1999 | EP0944604A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944601A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944595A1 5-cyclo indole compounds as 5-ht1d receptor ligands |
| 09/29/1999 | EP0944592A1 Vitamin d3 derivatives |
| 09/29/1999 | EP0944584A1 Benzamidoaldehydes and their use as cysteine protease inhibitors |
| 09/29/1999 | EP0944582A1 Ketobenzamides as calpain inhibitors |
| 09/29/1999 | EP0944580A2 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide release and/or its synthesis |
| 09/29/1999 | EP0944399A2 Covalent polar lipid conjugates for targeting |
| 09/29/1999 | EP0944391A1 Use of equilenin as an antioxidant |
| 09/29/1999 | EP0944390A1 USE OF 17$g(b)-DIHYDROEQUILENIN AS AN ANTIOXIDANT |
| 09/29/1999 | EP0944309A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof |
| 09/29/1999 | CN1230222A PTX-sensitive G proteins, prodn. and use thereof |
| 09/29/1999 | CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. |
| 09/29/1999 | CN1230195A Treatment of immune disorders |
| 09/29/1999 | CN1230186A Pyrazolopyridine compound and pharmaceutical use thereof |
| 09/29/1999 | CN1230184A Arylamino fused pyridines and pyrimidines |
| 09/29/1999 | CN1230180A D4 receptor selectivity piperazine derivatives |
| 09/29/1999 | CN1230174A Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect |
| 09/29/1999 | CN1230123A Inclusion complex containing indole selective serotonin agonist |
| 09/29/1999 | CN1230115A Use of chelating agent clioquinol for manufacture of pharmaceutical compsn. for treatment of alzheimer's disease |
| 09/29/1999 | CN1045294C Method for prepn. of indole derivatives |
| 09/29/1999 | CN1045293C Substituted pyrazoles compounds and medicinal compositions containing same |
| 09/29/1999 | CN1045291C Method for prepn. of substituted tetrahydroisoquinolin compound |
| 09/28/1999 | US5959115 Multistage reaction of catalytic hydrogenation, acylation and salt formation |
| 09/28/1999 | US5959110 Substituted tetrahydro-1h-naph(1,2,3-de)isoquinoline compound useful for treating nervous system disorders |
| 09/28/1999 | US5959107 Inhibitory activity on neuronal cell death (apoptotic cell death-type) caused by excessive apoptosis in a nervous system and they are useful for prevention or treatment of neurodegenerative disorders |
| 09/28/1999 | US5958962 Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| 09/28/1999 | US5958960 Excitatory amino acid receptor modulators |
| 09/28/1999 | US5958954 2,2-dialkyl-4-aryl-substituted benzopyran and benzothiopyran derivatives |
| 09/28/1999 | US5958945 Psychological disorders |
| 09/28/1999 | US5958943 A!-anellated pyrrole derivatives and their use in pharmacology |
| 09/28/1999 | US5958931 Phenyl-substituted 5H-thiazolo 3,2-A!pyrimidine derivative glutamate receptor antagonists |
| 09/28/1999 | US5958927 Psychological and nervous system disorders |
| 09/28/1999 | US5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 09/28/1999 | US5958921 Method for treating depression with olanzapine |
| 09/28/1999 | US5958910 Use of N-(4-aryl-thiazol-2-yl)-sulfonamides |
| 09/28/1999 | US5958903 Cholinesterase inhibitors |
| 09/28/1999 | US5958882 Compounds that inhibit T cell proliferation and methods using the same |
| 09/28/1999 | US5958767 Engraftable human neural stem cells |
| 09/28/1999 | US5958731 Cell junction PDZ protein |
| 09/28/1999 | US5958718 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 09/28/1999 | US5958710 The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and |
| 09/28/1999 | US5958709 Processes for identifying compounds that bind to the human Y4 receptor |
| 09/28/1999 | US5958409 Administering antitumor necrosis factor antibody to the human suffering with multiple sclerosis |
| 09/28/1999 | US5958401 Method of using IL-11 for treating psoriasis |
| 09/28/1999 | CA2178021C Tobacco substitute |
| 09/28/1999 | CA2133503C Orally administrable opioid formulations having extended duration of effect |
| 09/28/1999 | CA2017029C Composition |
| 09/26/1999 | CA2264260A1 Polynucleotide molecules encoding neospora proteins |
| 09/24/1999 | CA2249660A1 Novel compounds |
| 09/23/1999 | WO1999047670A1 Mammalian sodium channel proteins |
| 09/23/1999 | WO1999047545A2 Inhibitors of caspases |
| 09/23/1999 | WO1999047538A1 Cytokine receptor common gamma chain like |
| 09/23/1999 | WO1999047535A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 09/23/1999 | WO1999047524A1 Novel heterocyclic compounds |
| 09/23/1999 | WO1999047521A1 HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS |
| 09/23/1999 | WO1999047519A1 Crystalline form of paroxetine |
| 09/23/1999 | WO1999047517A1 Novel heterocyclic compounds |
| 09/23/1999 | WO1999047513A1 Heteroaromatic derivatives |
| 09/23/1999 | WO1999047508A1 Benzenesulfonamide-derivatives and their use as medicaments |
| 09/23/1999 | WO1999047490A1 Bicyclo[2.2.1]heptanes and related compounds |
| 09/23/1999 | WO1999047158A2 Therapeutic chemokine receptor antagonists |
| 09/23/1999 | WO1999047154A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | WO1999047142A1 Combination of a gaba-a alpha 5 inverse agonist and a nicotinic agonist |
| 09/23/1999 | WO1999047132A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 09/23/1999 | WO1999047131A2 Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor |
| 09/23/1999 | WO1999040905A3 Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases |
| 09/23/1999 | WO1999040112A8 Neuroprotective peptides and uses thereof |
| 09/23/1999 | WO1999038955A3 Mutant herpes simplex viruses and uses thereof |
| 09/23/1999 | WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 09/23/1999 | WO1999032510A9 Kappa receptor opioid peptides |